RBC Capital Starts Coverage of GE HealthCare Technologies

RBC Capital Markets initiated coverage of GE HealthCare Technologies Inc. (NASDAQ: GEHC) this week, putting a fresh analyst spotlight on one of the largest medical technology companies to emerge from General Electric's historic breakup. The move marks a notable expansion of Wall Street research coverage for the Chicago-based firm, which was spun off from GE in early 2023.

GE HealthCare Technologies operates across imaging systems, ultrasound equipment, patient monitoring, and pharmaceutical diagnostics — segments that have drawn sustained institutional interest as hospitals and health systems accelerate capital spending on advanced diagnostic tools. The initiation by RBC, a major Canadian-American investment bank with deep healthcare sector expertise, adds credibility to GEHC's standalone investment thesis.

Read more BofA Keeps Apple Buy Rating, Sees AI Shift Sparking Upgrades →

Analyst initiations of this kind typically signal that a brokerage sees sufficient trading volume and investor interest to justify dedicating research resources to a stock. For GEHC, which has worked to establish its identity as an independent public company, additional coverage from a top-tier firm like RBC Capital could improve liquidity and broaden the shareholder base by reaching the bank's institutional client network.

GE HealthCare has positioned itself as a pure-play medtech and diagnostics company, a strategic identity that separates it from the conglomerate legacy of its former parent. As the broader medtech sector navigates pricing pressures and evolving reimbursement landscapes, investor focus on companies with durable equipment cycles and software-enabled services — areas where GEHC competes — has intensified. RBC's entry into coverage adds another analytical voice to an already closely watched name.

Continue reading at Yahoo Finance.

Continue reading at Yahoo Finance →